Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year\u2019s Early Detection of Cancer conference in London.
New research, led by Professor Anindita Roy, is to be funded by families affected by childhood cancer through Children\u2019s Cancer and Leukaemia Group (CCLG)'s Special Named Fund programme.
Oxford researchers have been given a \u00a31 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.
David Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health, has been appointed as a Companion of the Order of Australia in the Australian King\u2019s Birthday Honours List.
Eight academics from the University of Oxford have joined the Royal Society as Fellows, including Professor Michael Dustin FRS, Kennedy Trust Professor of Molecular Immunology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) and Director of Research at the Kennedy Institute of Rheumatology.
Monica is one of 40 recipients of the 2023 Springboard Award, which is awarded to biomedical and health researchers in their first independent post to help launch their careers.
Oxford Cancer is pleased to announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation.
Dr Edward O'Neill will is to join Oxford University's Nuffield Department of Surgical Sciences after securing a prestigious Prostate Cancer UK Career Acceleration Fellowship.
Four University of Oxford researchers have been awarded European Research Council (ERC) Advanced Grants of \u20ac2.5 million each over five years to explore their most innovative and ambitious ideas. These grants recognise ground-breaking projects led by researchers with a track record of significant research achievements.
Dr Mark Hill was awarded the honour of Fellow of the Institute of Physics and Engineering in Medicine (FIPEM) after \u2018demonstrating scientific and professional attainment of outstanding merit\u2019.\r\n\r\nMark has over 35 years of experience in the field of radiation biology and physics, spanning basic, pre-clinical and clinically related research.
Dr Lennard Lee, academic clinical lecturer at the Department of Oncology was recognised as part of the InterAcademy Partnership Young Physician Leaders Programme 2022
A paper led by Dr Zhiyuan Hu from Professor Ahmed Ahmed\u2019s lab has won the Columbia Hospital for Women Research Foundation\u2019s 2020-2021 prize for impact.
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
![\"Academy](\"https://www.cancer.ox.ac.uk/news/oxford-cancer-researchers-elected-as-fellows-of-the-academy-of-medical-sciences/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n